Matt founded PTV and serves as its Managing Director.
He has spent his entire career in the private equity, venture capital, banking and finance industries and has served on numerous private and public company boards of directors. Matt is an Executive Committee member of The University of Texas Chancellor’s Council. He also serves on the Wake Forest University (WFU) Board of Trustees as well as the WFU Health Sciences Board of Directors.
Matt holds a BA and MBA from Wake Forest University.
Representative investments include: Apollo Endosurgery (IPO), Asuragen (Private), Cameron Health (Sold to Boston Scientific), Cardiva Medical (Private), IDEV (Sold to Abbott), Intuity Medical (Private), LDR (IPO), On-X Life Technologies (Sold to Cryolife), OsteoBiologics (Sold to Smith & Nephew).